Psoriasis and Cardiovascular Risk: Assessment by CUORE Project Risk Score in Italian Patients

Spyridoula Doukaki1, Valentina Caputo, Maria Rita Bongiorno

  • 1Department of Dermatology, University of Palermo, Via del Vespro 131, 90123 Palermo, Italy.

Insights

Psoriasis patients have a significantly higher cardiovascular risk compared to those without the condition. Early identification and management of cardiovascular risk factors in psoriasis is crucial for prevention.

Area of Science:

  • Dermatology
  • Cardiology
  • Epidemiology

Background:

  • Psoriasis is a prevalent inflammatory skin condition with debated links to cardiovascular disease.
  • Existing research indicates a potential increase in cardiovascular risk factors and diseases among psoriasis patients.
  • This study investigates the association between psoriasis and cardiovascular risk.

Purpose of the Study:

  • To assess the cardiovascular risk score in patients with psoriasis.
  • To explore the relationship between cardiovascular risk and specific psoriasis features.
  • To evaluate cardiovascular risk using the CUORE project risk score.

Main Methods:

  • A case-control study involving 210 psoriasis outpatients and 111 controls with other skin conditions.
  • Utilized the CUORE project risk score, designed for populations with low coronary heart disease rates.
  • Compared cardiovascular risk scores between psoriasis patients and controls.

Main Results:

  • Psoriasis patients exhibited a significantly higher CUORE project risk score than controls (6.80 ± 6.34 vs. 4.48 ± 4.38, P < 0.001).
  • Psoriasis patients face an elevated risk of major cardiovascular events compared to controls.
  • No significant correlation was found between cardiovascular risk and specific psoriasis characteristics.

Conclusions:

  • Psoriasis is associated with increased cardiovascular risk.
  • Routine screening for cardiovascular risk factors in psoriasis patients is recommended.
  • Proactive lifestyle modifications and therapeutic interventions are warranted for psoriasis patients to mitigate cardiovascular risks.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...